IP Verse

Vivacy competitive analysis

Explore the latest publications and patents granted to Vivacy, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Vivacy against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3574901	Injection Devices Comprising A Composition Of Hyaluronic Acid And Mepivacaine Hydrochloride	TEOXANE	Oct 26, 2022
EP3256097	Compositions And Methods For Improving Skin Appearance	ALLERGAN INDUSTRIE	Oct 5, 2022
EP3498262	Use Of A Gel Of Natural Polysaccharide(S) For The Preparation Of An Injectable Formulation For Treating Joint Degeneration	APTISSEN	May 31, 2022
EP3313452	Method For Preparing An Injectable Cross-Linked Hydrogel, Hydrogel Obtained; And Use Of The Obtained Hydrogel	KYLANE LABORATOIRES	Jun 4, 2020
EP3125961	Polysaccharide Soft Tissue Fillers With Improved Persistence	HTL	Jun 2, 2020
EP3027186	Composition Comprising Hyaluronic Acid And Mepivacaine	TEOXANE	May 4, 2020
EP2173324	Hyaluronic Acid Injectable Gel For Treating Joint Degeneration	ANTEIS	Jan 10, 2020
EP3166652	Hyaluronic Acid Gels Crosslinked By Sodium Trimetaphosphate	ALLERGAN INDUSTRIE	Jan 3, 2020
EP3027186	Composition Comprising Hyaluronic Acid And Mepivacaine	TEOXANE	Jun 21, 2019
EP2994090	Hyaluronic Acid Gels Crosslinked By Sodium Trimetaphosphate	ALLERGAN INDUSTRIE	Sep 5, 2018

Discover the latest PTAB cases involving Vivacy, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Vivacy with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
LABORATOIRES VIVACY	11	-	-	-	Highly Aggressive
ALLERGAN INDUSTRIE	-	11	-	10	Non-Active
ANTEIS	-	2	-	-	Non-Active
APTISSEN	-	2	-	-	Non-Active